Last updated on March 2019

Prevention of Episodic Migraine: Long-Term, Randomized, Open-Label Study to Evaluate the Safety and Tolerability of Oral Atogepant


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Migraine (Adult) | Neurologic Disorders | Headaches
  • Age: Between 18 - 80 Years
  • Gender: Male or Female

 

To be eligible a participant will be 18-80 years of age and must have:

  • At least a one year history of migraines that started before age 50.
  • 4 - 14 migraine attacks per month for at least the last 3 months
  • No more than 14 headache days on average in the 3 months prior to the first study visit
  • The ability to maintain and electronic diary (provided by research site) to document migraine episodes (provided by the research site)
  • No more than 14 headache days on average in the 3 months prior to the first study visit

Additional criteria may apply.

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.